|
1,2,5,6,7,8-hexahydro-2,6-naphthyridin-1-one
|
H682766-1g
|
≥97% |
1170830-85-9 |
1g
|
¥ 7760.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,2,5,6,7,8-hexahydro-2,6-naphthyridin-1-one
|
H682766-100mg
|
≥97% |
1170830-85-9 |
100mg
|
¥ 784.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-5g
|
≥97% |
130473-27-7 |
5g
|
¥ 9312.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-50g
|
≥97% |
130473-27-7 |
50g
|
¥ 49664.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-500mg
|
≥97% |
130473-27-7 |
500mg
|
¥ 2064.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-25g
|
≥97% |
130473-27-7 |
25g
|
¥ 31040.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-250mg
|
≥97% |
130473-27-7 |
250mg
|
¥ 1248.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-1g
|
≥97% |
130473-27-7 |
1g
|
¥ 3104.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-10g
|
≥97% |
130473-27-7 |
10g
|
¥ 15520.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid
|
H682739-100mg
|
≥97% |
130473-27-7 |
100mg
|
¥ 752.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,4R)-1-[(2S)-2-(4-aminobutanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[[4-(4-methylthiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;hydrochloride
|
H682719-500mg
|
≥97% |
2940858-65-9 |
500mg
|
¥ 16800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,4R)-1-[(2S)-2-(4-aminobutanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[[4-(4-methylthiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;hydrochloride
|
H682719-250mg
|
≥97% |
2940858-65-9 |
250mg
|
¥ 11760.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,4R)-1-[(2S)-2-(4-aminobutanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[[4-(4-methylthiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;hydrochloride
|
H682719-1g
|
≥97% |
2940858-65-9 |
1g
|
¥ 24000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,4R)-1-[(2S)-2-(4-aminobutanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[[4-(4-methylthiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide;hydrochloride
|
H682719-100mg
|
≥97% |
2940858-65-9 |
100mg
|
¥ 7056.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682686-5g
|
≥97% |
2940937-16-4 |
5g
|
¥ 38400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682686-500mg
|
≥97% |
2940937-16-4 |
500mg
|
¥ 8960.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682686-250mg
|
≥97% |
2940937-16-4 |
250mg
|
¥ 6272.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682686-1g
|
≥97% |
2940937-16-4 |
1g
|
¥ 12800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682686-10g
|
≥97% |
2940937-16-4 |
10g
|
¥ 64128.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(tert-butoxycarbonylamino)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682686-100mg
|
≥97% |
2940937-16-4 |
100mg
|
¥ 3760.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682684-5g
|
≥97% |
2940953-75-1 |
5g
|
¥ 31200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682684-500mg
|
≥97% |
2940953-75-1 |
500mg
|
¥ 7280.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682684-250mg
|
≥97% |
2940953-75-1 |
250mg
|
¥ 5104.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[4-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-1-yl]methyl acetate
|
H682684-1g
|
≥97% |
2940953-75-1 |
1g
|
¥ 10400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |